from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2499c/-

LFCtreatmentdescriptionclass of inhibitor

-0.742

Amikacinug/mL Amikacintranslation

-0.847

Cap5-10ug/mL Capreomycintranslation

-0.793

Rox10-50 ug/mL Roxithromycintranslation

-0.635

SM2-5 ug/mL Streptomycintranslation

-1.705

Tet5-10 ug/mL Tetracyclinetranslation

-0.409

Rif0.2-5ug/mL Rifampicintranscription

-0.157

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.507

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.848

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.209

CPZ10-50 ug/mL Chlorpromazinerespiration

0.351

Clofazimine10-13 ug/mL Clofaziminerespiration

0.023

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

5.112

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.903

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.389

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.142

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.127

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.110

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

3.590

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.349

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.401

KCN5-20 ug/mL Potassium cyaniderespiration

-0.107

NaN30.2-2 mM Sodium aziderespiration

0.677

Nigericin50 uM Nigericinrespiration

0.664

TRC10-150 ug/mL Triclosanrespiration

1.427

TRZ10-25 ug/mL Thioridazinerespiration

-0.113

Valinomycin0.5-10 uM Valinomycinrespiration

-0.788

ZnSO42 mM ZnSO4respiration

-0.317

menadione6-10 ug/mL Menadionerespiration

-0.355

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.281

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.180

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.172

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.780

NRP_1Non-replicating persistence stage 1dosRassociated

-0.271

Amp0.2mg/mL AmpicillincellWall

-0.392

Cephalexin20-100 ug/mL CephalexincellWall

-0.366

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.471

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.186

EMB10-20 ug/mL EthambutolcellWall

-0.512

Eta12-40 ug/mL EthionamidecellWall

-0.523

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.441

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.229

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.292

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.266

BZA0.12 mg/mL BenzamidearomaticAmides

-0.181

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.252

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.647

H2O24 mM hydrogen peroxideDNAdamaging

-0.212

Levo10 ug/mL LevofloxacinDNAdamaging

-0.669

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.940

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.457

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.438

UVUV-irradiationDNAdamaging

0.236

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.259

Antimycin12.5-50 ug/mL Antimycin A?

-0.224

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.721

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.363

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.719

PA8240.2-2 ug/mL PA-824?

0.332

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.019

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-0.088

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.140

methoxatin10-20 ug/mL Methoxatin?